| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ICL(R) | 61 | 48.4% | -0.15 | 55 | 58.5% |
| SCL(R) | 31 | 24.6% | -0.49 | 22 | 23.4% |
| PLP(R) | 12 | 9.5% | 0.42 | 16 | 17.0% |
| SPS(L) | 14 | 11.1% | -3.81 | 1 | 1.1% |
| CentralBrain-unspecified | 4 | 3.2% | -inf | 0 | 0.0% |
| IB | 3 | 2.4% | -inf | 0 | 0.0% |
| SPS(R) | 1 | 0.8% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns CL351 | % In | CV |
|---|---|---|---|---|---|
| CL107 (R) | 1 | ACh | 14 | 13.6% | 0.0 |
| PS096 (R) | 3 | GABA | 9 | 8.7% | 0.7 |
| PS326 (R) | 2 | Glu | 6 | 5.8% | 0.0 |
| CB4070 (R) | 2 | ACh | 5 | 4.9% | 0.6 |
| CB3074 (L) | 1 | ACh | 4 | 3.9% | 0.0 |
| CL064 (R) | 1 | GABA | 4 | 3.9% | 0.0 |
| CL225 (L) | 3 | ACh | 4 | 3.9% | 0.4 |
| PS096 (L) | 3 | GABA | 4 | 3.9% | 0.4 |
| CL287 (R) | 1 | GABA | 3 | 2.9% | 0.0 |
| GNG385 (R) | 1 | GABA | 3 | 2.9% | 0.0 |
| DNp39 (L) | 1 | ACh | 2 | 1.9% | 0.0 |
| PVLP063 (R) | 1 | ACh | 2 | 1.9% | 0.0 |
| PVLP065 (R) | 1 | ACh | 2 | 1.9% | 0.0 |
| LoVC25 (L) | 1 | ACh | 2 | 1.9% | 0.0 |
| PLP022 (R) | 1 | GABA | 2 | 1.9% | 0.0 |
| IB117 (R) | 1 | Glu | 2 | 1.9% | 0.0 |
| CL075_a (R) | 1 | ACh | 2 | 1.9% | 0.0 |
| IB058 (L) | 1 | Glu | 2 | 1.9% | 0.0 |
| PLP001 (L) | 1 | GABA | 2 | 1.9% | 0.0 |
| DNp27 (R) | 1 | ACh | 2 | 1.9% | 0.0 |
| PLP199 (R) | 2 | GABA | 2 | 1.9% | 0.0 |
| CL048 (R) | 1 | Glu | 1 | 1.0% | 0.0 |
| CL353 (R) | 1 | Glu | 1 | 1.0% | 0.0 |
| DNp27 (L) | 1 | ACh | 1 | 1.0% | 0.0 |
| SMP048 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| PS107 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| IB004_a (R) | 1 | Glu | 1 | 1.0% | 0.0 |
| LoVC27 (L) | 1 | Glu | 1 | 1.0% | 0.0 |
| CL171 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| CB4071 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| CB0061 (L) | 1 | ACh | 1 | 1.0% | 0.0 |
| CL354 (L) | 1 | Glu | 1 | 1.0% | 0.0 |
| WED129 (L) | 1 | ACh | 1 | 1.0% | 0.0 |
| AN04B023 (L) | 1 | ACh | 1 | 1.0% | 0.0 |
| PVLP109 (L) | 1 | ACh | 1 | 1.0% | 0.0 |
| LoVP32 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| AVLP212 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| LT63 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| SLP080 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| CL316 (L) | 1 | GABA | 1 | 1.0% | 0.0 |
| PLP177 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| ATL031 (R) | 1 | unc | 1 | 1.0% | 0.0 |
| LoVCLo2 (R) | 1 | unc | 1 | 1.0% | 0.0 |
| MeVC3 (R) | 1 | ACh | 1 | 1.0% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 1 | 1.0% | 0.0 |
| LoVC12 (R) | 1 | GABA | 1 | 1.0% | 0.0 |
| downstream partner | # | NT | conns CL351 | % Out | CV |
|---|---|---|---|---|---|
| CL130 (R) | 1 | ACh | 17 | 13.4% | 0.0 |
| CB4070 (R) | 4 | ACh | 9 | 7.1% | 1.0 |
| CL354 (L) | 2 | Glu | 6 | 4.7% | 0.7 |
| CL171 (R) | 3 | ACh | 6 | 4.7% | 0.4 |
| CL354 (R) | 2 | Glu | 5 | 3.9% | 0.6 |
| CB2300 (R) | 1 | ACh | 4 | 3.1% | 0.0 |
| IB117 (R) | 1 | Glu | 4 | 3.1% | 0.0 |
| LoVC5 (R) | 1 | GABA | 4 | 3.1% | 0.0 |
| CL353 (R) | 2 | Glu | 4 | 3.1% | 0.5 |
| SMP460 (R) | 1 | ACh | 3 | 2.4% | 0.0 |
| PLP029 (R) | 1 | Glu | 3 | 2.4% | 0.0 |
| PLP032 (R) | 1 | ACh | 3 | 2.4% | 0.0 |
| IB004_b (R) | 1 | Glu | 2 | 1.6% | 0.0 |
| IB109 (R) | 1 | Glu | 2 | 1.6% | 0.0 |
| SMP459 (R) | 1 | ACh | 2 | 1.6% | 0.0 |
| CL302 (R) | 1 | ACh | 2 | 1.6% | 0.0 |
| CL085_b (R) | 1 | ACh | 2 | 1.6% | 0.0 |
| PLP076 (R) | 1 | GABA | 2 | 1.6% | 0.0 |
| LoVP31 (R) | 1 | ACh | 2 | 1.6% | 0.0 |
| CL144 (R) | 1 | Glu | 2 | 1.6% | 0.0 |
| CL309 (R) | 1 | ACh | 2 | 1.6% | 0.0 |
| AVLP708m (R) | 1 | ACh | 2 | 1.6% | 0.0 |
| AVLP464 (R) | 1 | GABA | 2 | 1.6% | 0.0 |
| LoVP91 (R) | 1 | GABA | 1 | 0.8% | 0.0 |
| LoVC7 (R) | 1 | GABA | 1 | 0.8% | 0.0 |
| LAL199 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| IB004_a (R) | 1 | Glu | 1 | 0.8% | 0.0 |
| CL225 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL355 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| CB2737 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| LoVC26 (L) | 1 | Glu | 1 | 0.8% | 0.0 |
| CB4073 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL170 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CB4071 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL091 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL225 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL245 (R) | 1 | Glu | 1 | 0.8% | 0.0 |
| CL089_a2 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL161_a (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| MeVC_unclear (R) | 1 | Glu | 1 | 0.8% | 0.0 |
| AN04B023 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| PLP037 (R) | 1 | Glu | 1 | 0.8% | 0.0 |
| CL085_c (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL088_a (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| DNpe053 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL088_b (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL083 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| SMP375 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| PS158 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL161_b (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| PLP259 (R) | 1 | unc | 1 | 0.8% | 0.0 |
| CL107 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| IB120 (R) | 1 | Glu | 1 | 0.8% | 0.0 |
| DNp41 (L) | 1 | ACh | 1 | 0.8% | 0.0 |
| PLP177 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| PLP208 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| CL157 (R) | 1 | ACh | 1 | 0.8% | 0.0 |
| LoVC18 (R) | 1 | DA | 1 | 0.8% | 0.0 |
| LoVC12 (R) | 1 | GABA | 1 | 0.8% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.8% | 0.0 |
